Pharma & Healthcare
Global Urea Cycle Disorder (UCD) Drugs Market Research Report 2026
- Feb 24, 26
- ID: 718077
- Pages: 112
- Figures: 112
- Views: 3
This report delivers a comprehensive overview of the global Urea Cycle Disorder (UCD) Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Urea Cycle Disorder (UCD) Drugs. The Urea Cycle Disorder (UCD) Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Urea Cycle Disorder (UCD) Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Urea Cycle Disorder (UCD) Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Horizon Pharma
Immedica Pharma
Weijian Pharmaceutical
Zhaoke Pharmaceutical
Kyowa Hakko Bio
Recordati Rare Diseases
5
Segment by Type
Glycerol Phenylbutyrate
Sodium Phenylbutyrate
Sodium Benzoate
Other
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Urea Cycle Disorder (UCD) Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Urea Cycle Disorder (UCD) Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Urea Cycle Disorder (UCD) Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Urea Cycle Disorder (UCD) Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Horizon Pharma
Immedica Pharma
Weijian Pharmaceutical
Zhaoke Pharmaceutical
Kyowa Hakko Bio
Recordati Rare Diseases
5
Segment by Type
Glycerol Phenylbutyrate
Sodium Phenylbutyrate
Sodium Benzoate
Other
by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Urea Cycle Disorder (UCD) Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Urea Cycle Disorder (UCD) Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Urea Cycle Disorder (UCD) Drugs Market Overview
1.1 Product Definition
1.2 Urea Cycle Disorder (UCD) Drugs by Type
1.2.1 Global Urea Cycle Disorder (UCD) Drugs Market Value by Type: 2025 vs 2032
1.2.2 Glycerol Phenylbutyrate
1.2.3 Sodium Phenylbutyrate
1.2.4 Sodium Benzoate
1.2.5 Other
1.3 Urea Cycle Disorder (UCD) Drugs by Application
1.3.1 Global Urea Cycle Disorder (UCD) Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Urea Cycle Disorder (UCD) Drugs Market Size Estimates and Forecasts
1.4.1 Global Urea Cycle Disorder (UCD) Drugs Revenue 2021–2032
1.4.2 Global Urea Cycle Disorder (UCD) Drugs Sales 2021–2032
1.4.3 Global Urea Cycle Disorder (UCD) Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Urea Cycle Disorder (UCD) Drugs Market Competition by Manufacturers
2.1 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Urea Cycle Disorder (UCD) Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Urea Cycle Disorder (UCD) Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Date of Entry into the Industry
2.8 Global Urea Cycle Disorder (UCD) Drugs Market Competitive Situation and Trends
2.8.1 Global Urea Cycle Disorder (UCD) Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Urea Cycle Disorder (UCD) Drugs Players Market Share by Revenue
2.8.3 Global Urea Cycle Disorder (UCD) Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Urea Cycle Disorder (UCD) Drugs Market Scenario by Region
3.1 Global Urea Cycle Disorder (UCD) Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2021–2032
3.2.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2021–2026
3.2.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2027–2032
3.3 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2021–2032
3.3.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2021–2026
3.3.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2027–2032
3.4 North America Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.4.1 North America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.4.3 North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.5.1 Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.5.3 Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.7.1 Latin America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.7.3 Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021–2032)
4.1.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021–2026)
4.1.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2027–2032)
4.1.3 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2021–2032)
4.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2021–2032)
4.2.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2021–2026)
4.2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2027–2032)
4.2.3 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Urea Cycle Disorder (UCD) Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021–2032)
5.1.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021–2026)
5.1.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2027–2032)
5.1.3 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2021–2032)
5.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2021–2032)
5.2.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2021–2026)
5.2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2027–2032)
5.2.3 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Urea Cycle Disorder (UCD) Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Horizon Pharma
6.1.1 Horizon Pharma Company Information
6.1.2 Horizon Pharma Description and Business Overview
6.1.3 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.1.5 Horizon Pharma Recent Developments/Updates
6.2 Immedica Pharma
6.2.1 Immedica Pharma Company Information
6.2.2 Immedica Pharma Description and Business Overview
6.2.3 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.2.5 Immedica Pharma Recent Developments/Updates
6.3 Weijian Pharmaceutical
6.3.1 Weijian Pharmaceutical Company Information
6.3.2 Weijian Pharmaceutical Description and Business Overview
6.3.3 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.3.5 Weijian Pharmaceutical Recent Developments/Updates
6.4 Zhaoke Pharmaceutical
6.4.1 Zhaoke Pharmaceutical Company Information
6.4.2 Zhaoke Pharmaceutical Description and Business Overview
6.4.3 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.4.5 Zhaoke Pharmaceutical Recent Developments/Updates
6.5 Kyowa Hakko Bio
6.5.1 Kyowa Hakko Bio Company Information
6.5.2 Kyowa Hakko Bio Description and Business Overview
6.5.3 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.5.5 Kyowa Hakko Bio Recent Developments/Updates
6.6 Recordati Rare Diseases
6.6.1 Recordati Rare Diseases Company Information
6.6.2 Recordati Rare Diseases Description and Business Overview
6.6.3 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.6.5 Recordati Rare Diseases Recent Developments/Updates
6.7 5
6.7.1 5 Company Information
6.7.2 5 Description and Business Overview
6.7.3 5 Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 5 Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.7.5 5 Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urea Cycle Disorder (UCD) Drugs Industry Chain Analysis
7.2 Urea Cycle Disorder (UCD) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urea Cycle Disorder (UCD) Drugs Production Mode & Process Analysis
7.4 Urea Cycle Disorder (UCD) Drugs Sales and Marketing
7.4.1 Urea Cycle Disorder (UCD) Drugs Sales Channels
7.4.2 Urea Cycle Disorder (UCD) Drugs Distributors
7.5 Urea Cycle Disorder (UCD) Drugs Customer Analysis
8 Urea Cycle Disorder (UCD) Drugs Market Dynamics
8.1 Urea Cycle Disorder (UCD) Drugs Industry Trends
8.2 Urea Cycle Disorder (UCD) Drugs Market Drivers
8.3 Urea Cycle Disorder (UCD) Drugs Market Challenges
8.4 Urea Cycle Disorder (UCD) Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Urea Cycle Disorder (UCD) Drugs by Type
1.2.1 Global Urea Cycle Disorder (UCD) Drugs Market Value by Type: 2025 vs 2032
1.2.2 Glycerol Phenylbutyrate
1.2.3 Sodium Phenylbutyrate
1.2.4 Sodium Benzoate
1.2.5 Other
1.3 Urea Cycle Disorder (UCD) Drugs by Application
1.3.1 Global Urea Cycle Disorder (UCD) Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Urea Cycle Disorder (UCD) Drugs Market Size Estimates and Forecasts
1.4.1 Global Urea Cycle Disorder (UCD) Drugs Revenue 2021–2032
1.4.2 Global Urea Cycle Disorder (UCD) Drugs Sales 2021–2032
1.4.3 Global Urea Cycle Disorder (UCD) Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Urea Cycle Disorder (UCD) Drugs Market Competition by Manufacturers
2.1 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Urea Cycle Disorder (UCD) Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Urea Cycle Disorder (UCD) Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Date of Entry into the Industry
2.8 Global Urea Cycle Disorder (UCD) Drugs Market Competitive Situation and Trends
2.8.1 Global Urea Cycle Disorder (UCD) Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Urea Cycle Disorder (UCD) Drugs Players Market Share by Revenue
2.8.3 Global Urea Cycle Disorder (UCD) Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Urea Cycle Disorder (UCD) Drugs Market Scenario by Region
3.1 Global Urea Cycle Disorder (UCD) Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2021–2032
3.2.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2021–2026
3.2.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Region: 2027–2032
3.3 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2021–2032
3.3.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2021–2026
3.3.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2027–2032
3.4 North America Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.4.1 North America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.4.3 North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.5.1 Europe Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.5.3 Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Urea Cycle Disorder (UCD) Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.7.1 Latin America Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.7.3 Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021–2032)
4.1.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2021–2026)
4.1.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Type (2027–2032)
4.1.3 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2021–2032)
4.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2021–2032)
4.2.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2021–2026)
4.2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Type (2027–2032)
4.2.3 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Urea Cycle Disorder (UCD) Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021–2032)
5.1.1 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2021–2026)
5.1.2 Global Urea Cycle Disorder (UCD) Drugs Sales by Application (2027–2032)
5.1.3 Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2021–2032)
5.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2021–2032)
5.2.1 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2021–2026)
5.2.2 Global Urea Cycle Disorder (UCD) Drugs Revenue by Application (2027–2032)
5.2.3 Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Urea Cycle Disorder (UCD) Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Horizon Pharma
6.1.1 Horizon Pharma Company Information
6.1.2 Horizon Pharma Description and Business Overview
6.1.3 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.1.5 Horizon Pharma Recent Developments/Updates
6.2 Immedica Pharma
6.2.1 Immedica Pharma Company Information
6.2.2 Immedica Pharma Description and Business Overview
6.2.3 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.2.5 Immedica Pharma Recent Developments/Updates
6.3 Weijian Pharmaceutical
6.3.1 Weijian Pharmaceutical Company Information
6.3.2 Weijian Pharmaceutical Description and Business Overview
6.3.3 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.3.5 Weijian Pharmaceutical Recent Developments/Updates
6.4 Zhaoke Pharmaceutical
6.4.1 Zhaoke Pharmaceutical Company Information
6.4.2 Zhaoke Pharmaceutical Description and Business Overview
6.4.3 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.4.5 Zhaoke Pharmaceutical Recent Developments/Updates
6.5 Kyowa Hakko Bio
6.5.1 Kyowa Hakko Bio Company Information
6.5.2 Kyowa Hakko Bio Description and Business Overview
6.5.3 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.5.5 Kyowa Hakko Bio Recent Developments/Updates
6.6 Recordati Rare Diseases
6.6.1 Recordati Rare Diseases Company Information
6.6.2 Recordati Rare Diseases Description and Business Overview
6.6.3 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.6.5 Recordati Rare Diseases Recent Developments/Updates
6.7 5
6.7.1 5 Company Information
6.7.2 5 Description and Business Overview
6.7.3 5 Urea Cycle Disorder (UCD) Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 5 Urea Cycle Disorder (UCD) Drugs Product Portfolio
6.7.5 5 Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Urea Cycle Disorder (UCD) Drugs Industry Chain Analysis
7.2 Urea Cycle Disorder (UCD) Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Urea Cycle Disorder (UCD) Drugs Production Mode & Process Analysis
7.4 Urea Cycle Disorder (UCD) Drugs Sales and Marketing
7.4.1 Urea Cycle Disorder (UCD) Drugs Sales Channels
7.4.2 Urea Cycle Disorder (UCD) Drugs Distributors
7.5 Urea Cycle Disorder (UCD) Drugs Customer Analysis
8 Urea Cycle Disorder (UCD) Drugs Market Dynamics
8.1 Urea Cycle Disorder (UCD) Drugs Industry Trends
8.2 Urea Cycle Disorder (UCD) Drugs Market Drivers
8.3 Urea Cycle Disorder (UCD) Drugs Market Challenges
8.4 Urea Cycle Disorder (UCD) Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Urea Cycle Disorder (UCD) Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Urea Cycle Disorder (UCD) Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Urea Cycle Disorder (UCD) Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Urea Cycle Disorder (UCD) Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Urea Cycle Disorder (UCD) Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Urea Cycle Disorder (UCD) Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Urea Cycle Disorder (UCD) Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Urea Cycle Disorder (UCD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Horizon Pharma Company Information
Table 71. Horizon Pharma Description and Business Overview
Table 72. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product
Table 74. Horizon Pharma Recent Developments/Updates
Table 75. Immedica Pharma Company Information
Table 76. Immedica Pharma Description and Business Overview
Table 77. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product
Table 79. Immedica Pharma Recent Developments/Updates
Table 80. Weijian Pharmaceutical Company Information
Table 81. Weijian Pharmaceutical Description and Business Overview
Table 82. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product
Table 84. Weijian Pharmaceutical Recent Developments/Updates
Table 85. Zhaoke Pharmaceutical Company Information
Table 86. Zhaoke Pharmaceutical Description and Business Overview
Table 87. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product
Table 89. Zhaoke Pharmaceutical Recent Developments/Updates
Table 90. Kyowa Hakko Bio Company Information
Table 91. Kyowa Hakko Bio Description and Business Overview
Table 92. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product
Table 94. Kyowa Hakko Bio Recent Developments/Updates
Table 95. Recordati Rare Diseases Company Information
Table 96. Recordati Rare Diseases Description and Business Overview
Table 97. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product
Table 99. Recordati Rare Diseases Recent Developments/Updates
Table 100. 5 Company Information
Table 101. 5 Description and Business Overview
Table 102. 5 Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. 5 Urea Cycle Disorder (UCD) Drugs Product
Table 104. 5 Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Urea Cycle Disorder (UCD) Drugs Distributors List
Table 108. Urea Cycle Disorder (UCD) Drugs Customers List
Table 109. Urea Cycle Disorder (UCD) Drugs Market Trends
Table 110. Urea Cycle Disorder (UCD) Drugs Market Drivers
Table 111. Urea Cycle Disorder (UCD) Drugs Market Challenges
Table 112. Urea Cycle Disorder (UCD) Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Urea Cycle Disorder (UCD) Drugs
Figure 2. Global Urea Cycle Disorder (UCD) Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Urea Cycle Disorder (UCD) Drugs Market Share by Type: 2025 & 2032
Figure 4. Glycerol Phenylbutyrate Product Picture
Figure 5. Sodium Phenylbutyrate Product Picture
Figure 6. Sodium Benzoate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Urea Cycle Disorder (UCD) Drugs Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Urea Cycle Disorder (UCD) Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Urea Cycle Disorder (UCD) Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units), 2021–2032
Figure 16. Global Urea Cycle Disorder (UCD) Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Urea Cycle Disorder (UCD) Drugs Report Years Considered
Figure 18. Urea Cycle Disorder (UCD) Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Urea Cycle Disorder (UCD) Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Urea Cycle Disorder (UCD) Drugs Players: Market Share by Revenue in Urea Cycle Disorder (UCD) Drugs in 2025
Figure 21. Urea Cycle Disorder (UCD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Urea Cycle Disorder (UCD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Urea Cycle Disorder (UCD) Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Urea Cycle Disorder (UCD) Drugs by Type (2021–2032)
Figure 56. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Urea Cycle Disorder (UCD) Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Urea Cycle Disorder (UCD) Drugs by Application (2021–2032)
Figure 59. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Urea Cycle Disorder (UCD) Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Urea Cycle Disorder (UCD) Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Urea Cycle Disorder (UCD) Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Urea Cycle Disorder (UCD) Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Urea Cycle Disorder (UCD) Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Urea Cycle Disorder (UCD) Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Urea Cycle Disorder (UCD) Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Urea Cycle Disorder (UCD) Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Urea Cycle Disorder (UCD) Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Urea Cycle Disorder (UCD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Urea Cycle Disorder (UCD) Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Urea Cycle Disorder (UCD) Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Horizon Pharma Company Information
Table 71. Horizon Pharma Description and Business Overview
Table 72. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Horizon Pharma Urea Cycle Disorder (UCD) Drugs Product
Table 74. Horizon Pharma Recent Developments/Updates
Table 75. Immedica Pharma Company Information
Table 76. Immedica Pharma Description and Business Overview
Table 77. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Immedica Pharma Urea Cycle Disorder (UCD) Drugs Product
Table 79. Immedica Pharma Recent Developments/Updates
Table 80. Weijian Pharmaceutical Company Information
Table 81. Weijian Pharmaceutical Description and Business Overview
Table 82. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Weijian Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product
Table 84. Weijian Pharmaceutical Recent Developments/Updates
Table 85. Zhaoke Pharmaceutical Company Information
Table 86. Zhaoke Pharmaceutical Description and Business Overview
Table 87. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zhaoke Pharmaceutical Urea Cycle Disorder (UCD) Drugs Product
Table 89. Zhaoke Pharmaceutical Recent Developments/Updates
Table 90. Kyowa Hakko Bio Company Information
Table 91. Kyowa Hakko Bio Description and Business Overview
Table 92. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Kyowa Hakko Bio Urea Cycle Disorder (UCD) Drugs Product
Table 94. Kyowa Hakko Bio Recent Developments/Updates
Table 95. Recordati Rare Diseases Company Information
Table 96. Recordati Rare Diseases Description and Business Overview
Table 97. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Recordati Rare Diseases Urea Cycle Disorder (UCD) Drugs Product
Table 99. Recordati Rare Diseases Recent Developments/Updates
Table 100. 5 Company Information
Table 101. 5 Description and Business Overview
Table 102. 5 Urea Cycle Disorder (UCD) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. 5 Urea Cycle Disorder (UCD) Drugs Product
Table 104. 5 Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Urea Cycle Disorder (UCD) Drugs Distributors List
Table 108. Urea Cycle Disorder (UCD) Drugs Customers List
Table 109. Urea Cycle Disorder (UCD) Drugs Market Trends
Table 110. Urea Cycle Disorder (UCD) Drugs Market Drivers
Table 111. Urea Cycle Disorder (UCD) Drugs Market Challenges
Table 112. Urea Cycle Disorder (UCD) Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Urea Cycle Disorder (UCD) Drugs
Figure 2. Global Urea Cycle Disorder (UCD) Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Urea Cycle Disorder (UCD) Drugs Market Share by Type: 2025 & 2032
Figure 4. Glycerol Phenylbutyrate Product Picture
Figure 5. Sodium Phenylbutyrate Product Picture
Figure 6. Sodium Benzoate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Urea Cycle Disorder (UCD) Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Urea Cycle Disorder (UCD) Drugs Market Share by Application: 2025 & 2032
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Urea Cycle Disorder (UCD) Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Urea Cycle Disorder (UCD) Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Urea Cycle Disorder (UCD) Drugs Sales (K Units), 2021–2032
Figure 16. Global Urea Cycle Disorder (UCD) Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Urea Cycle Disorder (UCD) Drugs Report Years Considered
Figure 18. Urea Cycle Disorder (UCD) Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Urea Cycle Disorder (UCD) Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Urea Cycle Disorder (UCD) Drugs Players: Market Share by Revenue in Urea Cycle Disorder (UCD) Drugs in 2025
Figure 21. Urea Cycle Disorder (UCD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Urea Cycle Disorder (UCD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Urea Cycle Disorder (UCD) Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Urea Cycle Disorder (UCD) Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Urea Cycle Disorder (UCD) Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Urea Cycle Disorder (UCD) Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Urea Cycle Disorder (UCD) Drugs by Type (2021–2032)
Figure 56. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Urea Cycle Disorder (UCD) Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Urea Cycle Disorder (UCD) Drugs by Application (2021–2032)
Figure 59. Global Urea Cycle Disorder (UCD) Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Urea Cycle Disorder (UCD) Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232